Quantifying Retinal Microvascular Morphology in Schizophrenia Using Swept-Source Optical Coherence Tomography Angiography.
cognition
early-course schizophrenia
microvascular
schizophrenia
swept-source optical coherence tomography angiography
Journal
Schizophrenia bulletin
ISSN: 1745-1701
Titre abrégé: Schizophr Bull
Pays: United States
ID NLM: 0236760
Informations de publication
Date de publication:
21 01 2022
21 01 2022
Historique:
pubmed:
24
9
2021
medline:
3
3
2022
entrez:
23
9
2021
Statut:
ppublish
Résumé
Retinovascular changes are reported on fundus imaging in schizophrenia (SZ). This is the first study to use swept-source optical coherence tomography angiography (OCT-A) to comprehensively examine retinal microvascular changes in SZ. This study included 30 patients with SZ/schizoaffective disorder (8 early and 15 chronic) and 22 healthy controls (HCs). All assessments were performed at Beth Israel Deaconess Medical Center and Massachusetts Eye and Ear. All participants underwent swept-source OCT-A of right (oculus dextrus [OD]) and left (oculus sinister [OS]) eye, clinical, and cognitive assessments. Macular OCT-A images (6 × 6 mm) were collected with the DRI Topcon Triton for superficial, deep, and choriocapillaris vascular regions. Microvasculature was quantified using vessel density (VD), skeletonized vessel density (SVD), fractal dimension (FD), and vessel diameter index (VDI). Twenty-one HCs and 26 SZ subjects were included. Compared to HCs, SZ patients demonstrated higher overall OD superficial SVD, OD choriocapillaris VD, and OD choriocapillaris SVD, which were primarily observed in the central, central and outer superior, and central and outer inferior/superior, respectively. Early-course SZ subjects had significantly higher OD superficial VD, OD choriocapillaris SVD, and OD choriocapillaris FD compared to matched HCs. Higher bilateral (OU) superficial VD correlated with lower Positive and Negative Syndrome Scale (PANSS) positive scores, and higher OU deep VDI was associated with higher PANSS negative scores. These results suggest the presence of microvascular dysfunction associated with early-stage SZ. Clinical associations with microvascular alterations further implicate this hypothesis, with higher measures being associated with worse symptom severity and functioning in early stages and with lower symptom severity and better functioning in later stages.
Sections du résumé
BACKGROUND
Retinovascular changes are reported on fundus imaging in schizophrenia (SZ). This is the first study to use swept-source optical coherence tomography angiography (OCT-A) to comprehensively examine retinal microvascular changes in SZ.
METHODS
This study included 30 patients with SZ/schizoaffective disorder (8 early and 15 chronic) and 22 healthy controls (HCs). All assessments were performed at Beth Israel Deaconess Medical Center and Massachusetts Eye and Ear. All participants underwent swept-source OCT-A of right (oculus dextrus [OD]) and left (oculus sinister [OS]) eye, clinical, and cognitive assessments. Macular OCT-A images (6 × 6 mm) were collected with the DRI Topcon Triton for superficial, deep, and choriocapillaris vascular regions. Microvasculature was quantified using vessel density (VD), skeletonized vessel density (SVD), fractal dimension (FD), and vessel diameter index (VDI).
RESULTS
Twenty-one HCs and 26 SZ subjects were included. Compared to HCs, SZ patients demonstrated higher overall OD superficial SVD, OD choriocapillaris VD, and OD choriocapillaris SVD, which were primarily observed in the central, central and outer superior, and central and outer inferior/superior, respectively. Early-course SZ subjects had significantly higher OD superficial VD, OD choriocapillaris SVD, and OD choriocapillaris FD compared to matched HCs. Higher bilateral (OU) superficial VD correlated with lower Positive and Negative Syndrome Scale (PANSS) positive scores, and higher OU deep VDI was associated with higher PANSS negative scores.
CONCLUSIONS AND RELEVANCE
These results suggest the presence of microvascular dysfunction associated with early-stage SZ. Clinical associations with microvascular alterations further implicate this hypothesis, with higher measures being associated with worse symptom severity and functioning in early stages and with lower symptom severity and better functioning in later stages.
Identifiants
pubmed: 34554256
pii: 6374432
doi: 10.1093/schbul/sbab111
pmc: PMC8781445
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
80-89Subventions
Organisme : NCATS NIH HHS
ID : KL2 TR002542
Pays : United States
Informations de copyright
© The Author(s) 2021. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com.
Références
Am J Psychiatry. 2002 May;159(5):813-20
pubmed: 11986136
Asian J Psychiatr. 2020 Mar;49:101942
pubmed: 32070935
Mol Psychiatry. 2016 Apr;21(4):547-53
pubmed: 26033243
Schizophr Res. 2016 Jan;170(1):115-22
pubmed: 26692348
Am J Psychiatry. 2016 Apr 1;173(4):392-9
pubmed: 26684922
Ophthalmology. 2014 Aug;121(8):1572-8
pubmed: 24755005
J Anat. 2005 Apr;206(4):319-48
pubmed: 15817102
Front Hum Neurosci. 2014 Dec 22;8:1010
pubmed: 25566030
Acta Ophthalmol. 2020 Sep;98(6):e781-e787
pubmed: 32153141
Schizophr Bull. 2018 Jun 6;44(4):876-885
pubmed: 29272501
Am J Psychiatry. 2013 Dec;170(12):1451-9
pubmed: 24030514
Dialogues Clin Neurosci. 2006;8(1):71-8
pubmed: 16640116
Alzheimers Res Ther. 2020 Dec 4;12(1):161
pubmed: 33276820
Br J Ophthalmol. 2018 Feb;102(2):233-237
pubmed: 28600299
Nicotine Tob Res. 2012 Jan;14(1):75-8
pubmed: 22025545
Magn Reson Imaging. 2014 Sep;32(7):913-23
pubmed: 24928302
Biol Psychiatry. 1992 Feb 1;31(3):255-62
pubmed: 1547299
Eye Brain. 2021 Jan 08;13:1-20
pubmed: 33447120
Psychiatry Res Neuroimaging. 2020 May 30;299:111061
pubmed: 32145500
Complex Psychiatry. 2020 Oct;6(1-2):30-46
pubmed: 34883503
Schizophr Res. 2015 May;164(1-3):47-52
pubmed: 25694186
Schizophr Res. 2004 Jun 1;68(2-3):283-97
pubmed: 15099610
Alzheimers Dement (N Y). 2018 Sep 06;4:575-590
pubmed: 30406177
J Clin Med. 2020 Jun 02;9(6):
pubmed: 32498362
Br J Ophthalmol. 2020 Feb;104(2):157-161
pubmed: 31118186
Nat Rev Neurol. 2013 Jan;9(1):44-53
pubmed: 23165340
F1000Prime Rep. 2014 Jul 08;6:57
pubmed: 25184047
Mol Psychiatry. 2021 Jul;26(7):3430-3443
pubmed: 33060818
Psychiatry Res Neuroimaging. 2021 Feb 28;308:111234
pubmed: 33385763
Sci Rep. 2017 Nov 23;7(1):16201
pubmed: 29170485
Br J Psychiatry. 1990 Dec;157:853-9
pubmed: 2289094
Br J Psychiatry. 1978 Nov;133:429-35
pubmed: 728692
Invest Ophthalmol Vis Sci. 2016 Jul 1;57(9):OCT362-70
pubmed: 27409494
Schizophr Bull. 2020 Jan 4;46(1):43-53
pubmed: 31112601
PLoS One. 2019 Apr 2;14(4):e0214685
pubmed: 30939178
Dev Ophthalmol. 2016;56:13-7
pubmed: 27023108
Schizophr Bull. 1987;13(2):261-76
pubmed: 3616518
Prog Neuropsychopharmacol Biol Psychiatry. 2018 Aug 30;86:24-29
pubmed: 29772306
Clin Exp Optom. 2021 Sep;104(7):788-794
pubmed: 33689623
Eye Brain. 2021 Jul 24;13:205-217
pubmed: 34335068
Hum Brain Mapp. 2012 Jul;33(7):1741-9
pubmed: 21976373
Schizophr Res. 2017 May;183:75-81
pubmed: 27863935
J Affect Disord. 2019 Dec 1;259:98-103
pubmed: 31445346
Neuroimaging Clin N Am. 2020 Feb;30(1):73-83
pubmed: 31759574
Transl Psychiatry. 2015 Aug 11;5:e616
pubmed: 26261884
Bipolar Disord. 2021 Mar;23(2):130-140
pubmed: 32583570
J Neuroophthalmol. 2018 Sep;38(3):292-298
pubmed: 29040211
Am J Psychiatry. 2019 Jul 1;176(7):564-572
pubmed: 31164007
Psychiatry Res. 2012 Jul 30;203(1):89-94
pubmed: 22917503
Schizophr Bull. 2018 Jan 13;44(1):182-192
pubmed: 28575528